Published in Lung Cancer on May 16, 2013
Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget (2015) 0.94
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. Int J Mol Sci (2016) 0.91
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Int J Mol Sci (2015) 0.86
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int J Oncol (2013) 0.84
Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma. Pediatr Blood Cancer (2015) 0.81
Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor. Oncotarget (2016) 0.76
ATF5: development of oncogenic resistance to radiotherapy. Aging (Albany NY) (2015) 0.75
Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis. Oncotarget (2017) 0.75
Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness. Front Immunol (2017) 0.75
The IGF-1R/AKT pathway determines cell fate in response to p53. Transl Cancer Res (2016) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
p53 mutations in human cancers. Science (1991) 31.96
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
Oncogene-induced senescence as an initial barrier in lymphoma development. Nature (2005) 9.16
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell (2002) 6.76
Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys (2003) 6.16
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res (2001) 4.73
Focus on lung cancer. Cancer Cell (2002) 3.41
DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res (2002) 3.22
Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood (2005) 2.82
Therapy-induced senescence in cancer. J Natl Cancer Inst (2010) 2.45
Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol (2008) 2.30
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A (2001) 1.96
Cellular senescence and cancer treatment. Biochim Biophys Acta (2006) 1.96
Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol (2008) 1.89
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol (2005) 1.87
Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res (2003) 1.86
Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem (2002) 1.62
Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer (2006) 1.60
Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer. Cancer Res (2010) 1.52
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys (1998) 1.36
Current strategies to target p53 in cancer. Biochem Pharmacol (2010) 1.26
BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res (1995) 1.20
Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene (2003) 1.19
p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci (2000) 1.16
p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells. Int J Radiat Biol (2005) 1.10
MicroRNA regulation of ionizing radiation-induced premature senescence. Int J Radiat Oncol Biol Phys (2010) 1.08
Stress-induced premature senescence (SIPS)--influence of SIPS on radiotherapy. J Radiat Res (2008) 1.06
Inhibition of phosphatidylinostol 3-kinase uncouples H2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts. Exp Cell Res (2004) 1.04
p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Cancer (2004) 1.01
Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53. Br J Cancer (2010) 0.91
Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated. Mol Cancer (2010) 0.91
High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer. Cancer J (2007) 0.80
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76
Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69
Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest (2003) 3.55
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 3.46
Pulmonary complications after esophagectomy. Ann Thorac Surg (2002) 3.35
Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest (2012) 2.86
Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood (2005) 2.82
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest (2002) 2.79
Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med (2003) 2.71
American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest (2011) 2.61
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest (2014) 2.30
Lung cancer screening. Am J Respir Crit Care Med (2015) 2.14
New testing for lung cancer screening. Oncology (Williston Park) (2012) 2.06
Intensive care decision making in the seriously ill and elderly. Crit Care Med (2004) 1.98
A prospective multicenter study of competency metrics and educational interventions in the learning of bronchoscopy among new pulmonary fellows. Chest (2009) 1.97
One hundred years of lung cancer. Am J Respir Crit Care Med (2005) 1.90
Learning experience of linear endobronchial ultrasound among pulmonary trainees. Chest (2014) 1.55
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest (2011) 1.54
Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction. Int J Cardiol (2006) 1.53
Adult Bronchoscopy Training: Current State and Suggestions for the Future: CHEST Expert Panel Report. Chest (2015) 1.49
Effects of furosemide applied chronically to the round window: a model of metabolic presbyacusis. J Neurosci (2002) 1.48
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.43
POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. Chest (2015) 1.41
Pulmonary nodule volume: effects of reconstruction parameters on automated measurements--a phantom study. Radiology (2008) 1.41
Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis. J Thorac Oncol (2006) 1.38
Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med (2012) 1.33
Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res (2004) 1.30
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg (2003) 1.28
Hematopoietic stem cell origin of adipocytes. Exp Hematol (2009) 1.28
Nuclear factor kappaB deficiency is associated with auditory nerve degeneration and increased noise-induced hearing loss. J Neurosci (2006) 1.26
U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med (2010) 1.21
Spiral ligament pathology in quiet-aged gerbils. Hear Res (2002) 1.20
Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: mesenchymal cells and fibrocytes. J Comp Neurol (2006) 1.19
Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg (2008) 1.18
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest (2015) 1.16
Ouabain-induced cochlear nerve degeneration: synaptic loss and plasticity in a mouse model of auditory neuropathy. J Assoc Res Otolaryngol (2013) 1.15
Transplantation of mouse embryonic stem cells into the cochlea of an auditory-neuropathy animal model: effects of timing after injury. J Assoc Res Otolaryngol (2008) 1.15
Lung cancer: progress in diagnosis, staging and therapy. Respirology (2010) 1.14
Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest (2005) 1.14
Endobronchial ultrasound for the diagnosis and staging of lung cancer. Proc Am Thorac Soc (2009) 1.13
The treatment of advanced non-small cell lung cancer. Curr Opin Pulm Med (2005) 1.13
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg (2008) 1.10
Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J (2010) 1.09
A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest (2007) 1.08
Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointest Endosc (2004) 1.06
Attitudes and beliefs toward lung cancer screening among US Veterans. Chest (2013) 1.04
Measuring the quality of end-of-life care. J Pain Symptom Manage (2010) 1.04
Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One (2013) 1.03
PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation. FASEB J (2007) 1.02
Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians. Palliat Support Care (2008) 0.99
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol (2012) 0.98
Lung cancer. Invasive staging: the guidelines. Chest (2003) 0.98
The Master Settlement Agreement and its impact on tobacco use 10 years later: lessons for physicians about health policy making. Chest (2010) 0.97
Computed tomography screening for lung cancer. Ann Intern Med (2013) 0.96
Chronic reduction of endocochlear potential reduces auditory nerve activity: further confirmation of an animal model of metabolic presbyacusis. J Assoc Res Otolaryngol (2010) 0.95
Bronchoscopy for the diagnosis and staging of lung cancer. Semin Respir Crit Care Med (2008) 0.95
Pathologic changes of presbycusis begin in secondary processes and spread to primary processes of strial marginal cells. Hear Res (2005) 0.95
Age-related changes of myelin basic protein in mouse and human auditory nerve. PLoS One (2012) 0.94
Pulmonary involvement in Sjögren syndrome. Clin Chest Med (2010) 0.94
Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys (2005) 0.93
Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep (2009) 0.93
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J Physiol Lung Cell Mol Physiol (2014) 0.91
Hematopoietic stem cell senescence and long-term bone marrow injury. Cell Cycle (2006) 0.91
Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas. Clin Respir J (2012) 0.89
Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol (2015) 0.88
Combined endoscopic and open approach to the removal of expandable metallic tracheal stents. Arch Otolaryngol Head Neck Surg (2007) 0.88
Effects of gap junction uncoupling in the gerbil cochlea. Laryngoscope (2002) 0.86
Nurses' identification of important yet under-utilized end-of-life care skills for patients with life-limiting or terminal illnesses. J Palliat Med (2010) 0.86
Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol (2008) 0.85
Identification of ClC-2 and CIC-K2 chloride channels in cultured rat type IV spiral ligament fibrocytes. J Assoc Res Otolaryngol (2007) 0.85
Multidisciplinary management of lung cancer. N Engl J Med (2004) 0.85
Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol (2013) 0.85
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int J Oncol (2013) 0.84
Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. Chest (2009) 0.84
Feasibility study of performing IGRT system daily QA using a commercial QA device. J Appl Clin Med Phys (2011) 0.84
Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo. Radiother Oncol (2011) 0.84
Training for linear endobronchial ultrasound among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest (2013) 0.84
Maternal exposure to the mixture of organophosphorus pesticides induces reproductive dysfunction in the offspring. Environ Toxicol (2011) 0.83
Presence of surfactant lamellar bodies in normal and diseased sinus mucosa. ORL J Otorhinolaryngol Relat Spec (2005) 0.83
Screening for lung cancer. AJR Am J Roentgenol (2008) 0.83
Expression of CLC-K chloride channels in the rat cochlea. Hear Res (2006) 0.83
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer (2011) 0.83
Screening and early detection efforts in lung cancer. Cancer (2015) 0.83
Novel structures in marginal and intermediate cells presumably relate to functions of apical versus basal strial strata. Hear Res (2005) 0.83
Analysis of miR-376 RNA cluster members in the mouse inner ear. Int J Exp Pathol (2012) 0.82
A decade of advances in treatment of early-stage lung cancer. Clin Chest Med (2011) 0.82
A 79-year-old woman with a right paratracheal mass. Chest (2009) 0.81
The evolution of bronchoscopy training. Respiration (2008) 0.81
Hemophagocytic lymphohistiocytosis complicating influenza A infection. Pediatrics (2006) 0.81
Unmyelinated auditory type I spiral ganglion neurons in congenic Ly5.1 mice. J Comp Neurol (2010) 0.81